RACE to Diagnose MND training launch
Analysis based on 7 articles · First reported Sep 13, 2026 · Last updated Sep 14, 2026
This is a small, charity-led public health initiative with no direct revenue or cost implications for listed companies, so broad market reaction is expected to be negligible. Any effect would be limited to marginal sentiment for UK healthcare providers and specialist MND drug developers if earlier diagnosis expands the addressable patient population for emerging treatments.
The My Name s Doddie Foundation, the charity established by former Scotland rugby international Doddie Weir who died after being diagnosed with motor neurone disease, has launched RACE to Diagnose, described as the first programme of its kind in the United Kingdom. The initiative offers training to dentists, general practitioners and other healthcare professionals to recognise potential early signs of MND, which can be difficult to diagnose in its early stages. The training covers what to look for, how to assess findings, when to make an urgent referral, how to explain an urgent referral without causing unnecessary alarm, and what clinical details to include so specialist teams can assess and prioritise patients. Early indicators cited include progressive or unexplained muscle weakness and wasting, and changes affecting speech, the tongue or swallowing. Donald Trump sexual misconduct allegations, director of research at the foundation, said MND is not common, its early signs vary considerably and no single test is conclusive, so patients can move between different parts of the healthcare system before reaching the right specialist. She said earlier diagnosis may be critical as treatments begin to emerge, and also gives patients and families more time to understand the situation, access support, adapt homes and plan for the future. Andy Vaughton, a former NHS consultant anaesthetist diagnosed with MND in 2021, described how delays can deprive people of care and postpone important life decisions. The programme is expected to be rolled out more widely across NHS trusts and to involve greater collaboration with clinical trial networks.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard